Related Experiment Video
Updated: Nov 27, 2025
08:20
A New Toolkit for Evaluating Gene Functions using Conditional Cas9 Stabilization
Published on: September 2, 2021
4.4K
CRISPR/Cas9 from bench to bedside: what clinicians need to know before application?
Zi-Qing Li1,2, Chao-Hong Li3
1Department of Joint Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, 250021, China. ziqingli@upenn.edu.
Military Medical Research
|December 8, 2020
Summary
CRISPR gene editing, recognized by a Nobel Prize, offers precise DNA modification. This review addresses current limitations and future directions for its clinical application.
Area of Science:
- Biotechnology
- Molecular Biology
- Genetics
Background:
- CRISPR technology enables precise genome editing.
- Nobel Prize awarded for CRISPR development in 2020.
- Rapid advancements in CRISPR have occurred over the past decade.
Discussion:
- CRISPR technology faces challenges before clinical use.
- Current research focuses on overcoming CRISPR limitations.
- Addressing uncertainties is crucial for therapeutic applications.
Key Insights:
- CRISPR gene editing offers precise DNA modification.
- Nobel Prize highlights the significance of CRISPR technology.
- Ongoing research aims to enhance CRISPR safety and efficacy.
Outlook:
- Future directions involve refining CRISPR for clinical settings.
- Continued research will address remaining uncertainties.
- CRISPR technology holds promise for future therapeutics.
More Related Videos
Related Concept Videos
01:59CRISPR
55.4K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
55.4K
01:28CRISPR/Cas9 Genome Editing
1.1K
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
1.1K
02:53CRISPR and crRNAs
18.2K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
18.2K
02:31Homologous Recombination
59.8K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
59.8K